The incidence, frequency of complications and mortality of gastric ulcer di
sease are increased four-fold in the elderly taking non-steroidal anti-infl
ammatory drugs (NSAID). There is controversy as to whether this reflects in
creased usage of NSAID or specific vulnerability associated with age. We ha
ve investigated two possible mechanisms for this increase in gastrointestin
al effects in the elderly: (i) increased susceptibility to acute gastrotoxi
city; and (ii) reduced adaptation to NSAID, in a model of young (2 month),
mature (12 month) and aged (24 month) rats. Aspirin damaged 7.7% of the vol
ume of gastric mucosa in the young rat. In mature and aged rats, this incre
ased to 11.3% (P < 0.002 compared to control) and 21.9% (P < 0.005 compared
to control), respectively. Thus, aspirin caused a three-fold increase in t
he severity of acute gastric mucosal injury in aged animals. However, indom
ethacin, ibuprofen and L745 337 did not produce any significant acute gastr
ic mucosal damage in 2-, 12- or 24-month-old rats. Significant gastric adap
tation to diclofenac treatment occurred in both aged and young rats as meas
ured by gastric mucosal damage. The aged gastric mucosa adapted equally as
well as the young gastric mucosa to diclofenac. The findings of this study
provide only modest support to the hypothesis of increased vulnerability of
the stomach in the aged. Aspirin was associated with greater damage in the
aged. Adaptation to diclofenac-induced damage was not reduced in the aged
and there was not an increased susceptibility to damage by the non-aspirin
NSAID tested. The selective cyclo-oxygenase-2 inhibitor, L745 337, was the
least toxic agent and may represent a group of NSAID which cause fewer gast
rointestinal complications in the elderly.